Rare Thinking Summit Brings New Perspectives to Rare-Disease Research

Rare Thinking Summit | October 22–23, 2026

Researchers, clinicians, drug developers, investors, patient families, and advocates gathered in Lancaster, Pennsylvania, for Plowshare Therapies' inaugural Rare Thinking Summit. Their shared focus: exploring new approaches to developing treatments for rare diseases.

For families affected by rare genetic conditions, promising scientific discoveries do not always translate into available treatments. The challenges of developing therapies for very small patient populations require sustained collaboration across research, medicine, financing, and the communities these treatments are intended to serve.

The Rare Thinking Summit was organized to bring those perspectives into the same conversation and consider how different approaches might help advance rare-disease therapy development.

Dr. Kevin A. Strauss addresses attendees at the opening of the inaugural Rare Thinking Summit.
Dr. Kevin A. Strauss opens the inaugural Rare Thinking Summit in Lancaster, Pennsylvania.

Bringing Different Perspectives Together

Rare-disease treatment development involves decisions that extend well beyond the laboratory. Scientific feasibility, clinical needs, regulatory requirements, manufacturing, funding, and patient access all influence whether a potential therapy can progress.

The Summit created opportunities for people working across these areas to exchange ideas, examine challenges, and better understand the perspectives of others involved in the development process.

This interdisciplinary approach reflects an important part of Plowshare Therapies' mission: bringing scientific expertise and community commitment together to pursue treatments for patients with rare genetic diseases.

A participant holds a microphone and gestures while asking a question during a Rare Thinking Summit discussion.
Summit participants engage in discussion and raise questions during the program.

Keeping Patients and Families in the Conversation

The experiences of patients and their families provide an essential perspective on the urgency of rare-disease research. For families living with these conditions, the timeline for developing a treatment has immediate, personal significance.

The Summit brought patient-community perspectives into discussions with researchers, clinicians, and others involved in advancing potential therapies. Those conversations help connect the scientific and operational challenges of drug development with the needs of the people it is intended to benefit.

Creating Space for Practical Collaboration

Alongside presentations and broader discussions, the Summit included smaller working sessions that gave participants opportunities to explore specific challenges in greater depth.

These sessions offered a setting for sharing expertise, examining possible approaches, and identifying questions that deserve continued attention. The opportunity for direct dialogue among different disciplines was an important part of the event's design.

Rare Thinking Summit participants collaborate around a table during a breakout session, with notes displayed on a flip chart.
Participants work through ideas and challenges during a breakout session.

Building Connections Beyond the Summit

The inaugural Rare Thinking Summit brought together individuals and organizations with different experiences, areas of expertise, and relationships to rare-disease research.

The conversations held in Lancaster provide a foundation for continued engagement among those working to improve the development of therapies for small patient populations.

For Plowshare Therapies, the Summit also offered an opportunity to share its mission with a broader group of collaborators and stakeholders committed to advancing rare-disease research and treatment.

A large group of Rare Thinking Summit attendees poses together for a photograph at the Lancaster event.
Participants gather for a group photograph at the inaugural Rare Thinking Summit, October 22–23, 2026.

Continuing the Conversation

Advancing therapies for rare diseases requires scientific progress, thoughtful partnerships, and sustained attention to the people who need these treatments.

Plowshare Therapies is grateful to the speakers, attendees, families, and collaborators who contributed their perspectives to the inaugural Rare Thinking Summit. Their participation reflects the shared commitment that makes this work possible.

Event photography: Kelli Janke Photography.

Previous
Previous

Plowshare Therapies Completes First PLOW-101 Manufacturing Feasibility Run

Next
Next

Plowshare Therapies Makes National News